THERAVANCE INC's ticker is and the CUSIP is 88338T904. A total of 3 filers reported holding THERAVANCE INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $196,000 | -8.4% | 18,600 | -37.6% | 0.00% | – |
Q3 2015 | $214,000 | -74.5% | 29,800 | -35.8% | 0.00% | -100.0% |
Q2 2015 | $838,000 | +86.2% | 46,400 | +62.2% | 0.00% | – |
Q1 2015 | $450,000 | -44.4% | 28,600 | -50.0% | 0.00% | -100.0% |
Q4 2014 | $809,000 | -9.5% | 57,200 | +9.4% | 0.00% | 0.0% |
Q3 2014 | $894,000 | +156.9% | 52,300 | +347.0% | 0.00% | – |
Q2 2014 | $348,000 | -70.9% | 11,700 | -69.8% | 0.00% | -100.0% |
Q1 2014 | $1,197,000 | -29.0% | 38,700 | -18.2% | 0.00% | -50.0% |
Q4 2013 | $1,686,000 | +117.0% | 47,300 | +148.9% | 0.00% | +100.0% |
Q3 2013 | $777,000 | -30.9% | 19,000 | -34.9% | 0.00% | -50.0% |
Q2 2013 | $1,125,000 | – | 29,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|